COVID-19: FDA Device Center Chops In-Person Meetings, Lengthens Submission Deadlines
Executive Summary
The US agency’s device center has offered an extension on some submission deadlines and announced a transition to teleconferences from in-person meetings during the COVID-19 pandemic.